ARVN · NASDAQ
Arvinas (ARVN) Stock Price & Fundamentals
Arvinas (ARVN) closed at $357.26 on Oct 9, 2026, up 0.81% from the previous close of $354.38.
Share price, past year
1Y +18.51%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $357.26 |
| Sep 30, 2026 | $351.99 |
| Aug 31, 2026 | $355.87 |
| Jul 31, 2026 | $337.21 |
| Jun 30, 2026 | $307.60 |
| May 29, 2026 | $299.17 |
| Apr 30, 2026 | $292.81 |
| Mar 31, 2026 | $310.71 |
| Feb 27, 2026 | $302.70 |
| Jan 30, 2026 | $302.45 |
| Dec 31, 2025 | $304.62 |
| Nov 28, 2025 | $324.84 |
| Oct 31, 2025 | $298.38 |
Key statistics
- Market cap
- $23.33B
- P/E (TTM)
- 1,488.6
- EPS (TTM)
- $0.24
- Revenue (TTM)
- $316.70M
- Net income (TTM)
- $9.30M
- Shares outstanding
- 65.3M
- Dividend yield
- —
- 52-week range
- $291.61 – $359.42
Arvinas's market cap is $23.33B, based on a share price of $357.26 and 65.3M shares outstanding as of Jun 30, 2026.
Financials
Arvinas reported revenue of $262.60M for fiscal 2025, down 0.30% from fiscal 2024.
Arvinas reported a net loss of $80.80M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $262.60M | −0.3% | −$80.80M | −30.8% | −$1.14 | −$275.70M |
| FY2024ended Dec 31, 2024 | $263.40M | +235.5% | −$198.90M | −75.5% | −$2.77 | −$261.10M |
| FY2023ended Dec 31, 2023 | $78.50M | −40.3% | −$367.30M | −467.9% | −$6.62 | −$350.70M |
| FY2022ended Dec 31, 2022 | $131.40M | +145.2% | −$282.50M | −215.0% | −$5.31 | −$280.30M |
| FY2021ended Dec 31, 2021 | $53.60M | +107.0% | −$191.00M | −356.3% | −$3.82 | $554.70M |
| FY2020ended Dec 31, 2020 | $25.90M | −39.8% | −$119.30M | −460.6% | −$3.02 | −$96.10M |
| FY2019ended Dec 31, 2019 | $43.00M | +200.2% | −$70.30M | −163.5% | −$2.13 | −$46.90M |
| FY2018ended Dec 31, 2018 | $14.32M | +89.0% | −$41.48M | −289.6% | −$25.45 | −$18.95M |
| FY2017ended Dec 31, 2017 | $7.58M | — | −$24.05M | −317.3% | −$15.08 | $4.10M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $249.70M | $169.40M | $2.58 |
| Q1 FY2026ended Mar 31, 2026 | $15.60M | −$57.60M | −$0.90 |
| Q4 FY2025ended Dec 31, 2025 | $9.50M | −$67.40M | −$0.96 |
| Q3 FY2025ended Sep 30, 2025 | $41.90M | −$35.10M | −$0.48 |
| Q2 FY2025ended Jun 30, 2025 | $22.40M | −$61.20M | −$0.84 |
| Q1 FY2025ended Mar 31, 2025 | $188.80M | $82.90M | $1.14 |
| Q4 FY2024ended Dec 31, 2024 | $59.20M | −$45.10M | −$0.63 |
| Q3 FY2024ended Sep 30, 2024 | $102.40M | −$49.20M | −$0.68 |
Company profile
- Name
- Arvinas, Inc.
- Ticker
- ARVN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 395 Winchester Ave, 5 Science Park, New Haven, CT 06511
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001655759
Recent SEC filings
- Aug 4, 2026
- Aug 4, 2026
- Jun 25, 2026
- Jun 22, 2026
- Jun 16, 2026
- Jun 2, 2026
- May 12, 2026
- May 12, 2026
Frequently asked questions
What is Arvinas's stock price?
Arvinas (ARVN) closed at $357.26 on Oct 9, 2026, up 0.81% from the previous close of $354.38.
What is Arvinas's market cap?
Arvinas's market cap is $23.33B, based on a share price of $357.26 and 65.3M shares outstanding as of Jun 30, 2026.
How much revenue does Arvinas make?
Arvinas reported revenue of $262.60M for fiscal 2025, down 0.30% from fiscal 2024.
What is ARVN's P/E ratio?
Arvinas's price-to-earnings ratio is 1,488.6, based on trailing twelve-month diluted EPS of $0.24.
Does Arvinas pay a dividend?
Arvinas's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Arvinas, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures